ALWAYS READ THE LABEL AND FOLLOW THE DIRECTIONS FOR USE. Read the warnings available on dexcom.com/downloadsandguides before purchasing. Consult your healthcare professional to see if this product is right for you.
an easy Continuous Glucose Monitor (CGM) with essential alerts for people living with type 2 diabetes.†
‡ Smart device sold separately
Introducing Dexcom ONE+
The Dexcom ONE+ system features a simple, one-touch sensor applicator and mobile app‡ that displays both real-time and past glucose data.
With zero fingerpricking§, it continuously measures your glucose levels, day and night. It sends 24/7 automatic glucose readings to your smartphone app‡ or smartwatch.||
.png)
easy to use
- Self-start CGM which seamlessly integrates into your daily routine.
- Zero fingerpricks.§
- Easy & intuitive, all-in-one wearable.
- The smallest glucose sensors in Australia.^,1
- 30-minute warmup, fastest of any CGM on the market.#
- 10-day sensor wear with an additional 12-hour grace period.
- Waterproof when swimming, showering, and exercising.¶¶
‡ Smart device sold separately.
.jpg)
superior accuracy*,6
- Our most accurate CGM system¶,6 (alongside Dexcom G7), giving you the confidence to make informed treatment decisions.
- Accurate across all days of wear, glucose levels (2.2 to 22.2 mmol/L) and ages (2+).7-8
- Dexcom CGM is the #1 researched CGM brand in the world.‡‡
‡ Smart device sold separately.
better health outcomes2-6
- Dexcom is shown to
- Improve your quality of life9-10
- Improve HbA1c2-6
- Reduce highs and lows2-6
- Increase time in range2-6
Stay on track to be your best, with Dexcom CGM
Dexcom Follow app†† for friends & family
The Dexcom share feature allows friends, loved ones or caretakers to follow your glucose levels, giving you a circle of support.
Clarity Integration
Allows you to automatically share CGM data with your healthcare professional and see simple insights.
Outstanding technical support
There is a dedicated technical support team available to help empower, inform and support customers on their Dexcom journey.
Join our FREE Dexcom Warrior Program
Become part of a strong global advocacy movement. Connect with over 200,000 people worldwide and receive exclusive news and event invites.
Make more possible with Dexcom ONE+
Visit our online store to purchase a single sensor or our Dexcom ONE+ Monthly Subscription for automated shipping.
Have questions and wish to speak to a Dexcom representative?
Looking for technical assistance?
We offer outstanding technical support to ensure you can always access help when you need it!
Speak to one our our technical support team members today.
This product is a continuous glucose monitoring system indicated for the management of (type 1, type 2, gestational) diabetes in people age 2 years and older where self-monitoring of blood glucose (SMBG) is indicated.
§ If your glucose alerts and readings from Dexcom CGM do not match symptoms or expectations, use a blood glucose meter to make glucose treatment decisions. *As compared to Dexcom G6 System. †This product is indicated for persons with diabetes mellitus age 2 years and older where self-monitoring of blood glucose (SMBG) is indicated. ‡Smart device sold separately. For a list of compatible devices, visit www.dexcom.com/compatibility. || Compatible device required for CGM data on smartwatch. For a list of compatible devices, visit www.dexcom.com/compatibility. ¶ Compared to previous generations of Dexcom systems. # Dexcom ONE+ can complete warmup within 30 minutes, whereas other CGM brands require up to an hour or longer. ^ Based on published sizes of commercially available CGM systems in Australia. †† Separate Follow app and internet connection required. ‡‡ clinicaltrials.gov. ¶¶ The Dexcom G7 and Dexcom ONE+ sensor’s are waterproof and may be submerged under eight feet of water for up to 24 hours without failure when properly installed. ## Eligibility criteria applies. Visit ndss.com.au/cgm for more details.
1 Dexcom, Data on File, 2024. 2 Beck RW, et al. JAMA. 2017;317(4):371-378. 3 Beck RW, et al. Ann Intern Med. 2017;167(6):365-374. 4 Martens T, et al. JAMA. 2021;325(22):2262-2272. 5 Laffel LM, et al. JAMA. 2020;323(23):2388-2396. 6 Welsh JB, et al. J Diabetes Sci Technol. 2024;18(1):143-7. 7 Garg SK, et al. Diabetes Technol Ther. 2022;24(6):373-80. 8 Laffel LM, et al. J Diabetes Sci Technol. 2023;17(4):962-7. 9 Polonsky WH, et al. Diabetes Technol Ther. 2021;23(3):195-202. 10 Gilbert TR, et al. Diabetes Technol Ther. 2021;23(S1):S35-S39.
Dexcom, Dexcom G7, Dexcom G6, Dexcom ONE+, Dexcom Follow and Dexcom Share are registered trademarks of Dexcom, Inc. in the United States and/or other countries.
MAT-6940
